Scientific Reports vs PLOS ONE: An Honest Comparison for 2026

Scientific Reports and PLOS ONE look almost identical on paper. Both are megajournals. Both accept work based on technical soundness, not novelty. Both charge APCs in the $1,895-$1,895 range. Both publish tens of thousands of articles per year. And both have watched their impact factors slide downward as the journals grew larger.

The difference between them isn't scientific quality. It's publisher brand, community perception, and which disciplines have settled into each journal as their default landing zone for technically solid but non-breakthrough work.

If you're choosing between them, the decision matters more than most researchers realize.

The Numbers at a Glance

Both journals use the same editorial philosophy: they won't reject a technically valid study because the findings aren't novel or impactful enough. That's a deliberate choice, and it shaped what each journal became.

What "Megajournal" Means for Your Paper's Fate

The megajournal model emerged because journals like Nature and Cell were (and still are) rejecting technically sound research purely on novelty or perceived significance. That left a lot of valid science without a home. PLOS ONE created the template in 2006: if your methods are rigorous and your data supports your conclusions, we'll publish it.

Scientific Reports copied that model five years later, with Springer Nature's institutional weight behind it.

The practical consequence: both journals publish an enormous volume of work. This is good for authors who need publications and bad for anyone hoping to stand out in the volume. Your paper sits in a pool of 20,000-25,000 annual publications at each journal. Discovery happens primarily through search and citation, not through anyone browsing the journal.

Impact Factor: Why It Keeps Declining

Scientific Reports peaked at around 4.5 a few years back. It's now at 3.9. PLOS ONE peaked in 2010 at 4.4 - the highest of any journal in the world at the time - and has been falling since. It's now at 2.6.

This is structural, not a sign that quality has dropped. Both journals publish so much content that citation dilution is inevitable. Most published papers in any megajournal receive few citations. A handful receive many. The average stays low.

For most researchers, a 3.8 vs 2.9 difference doesn't matter for career evaluation. What matters is whether the journal is indexed, respected in your field, and whether the paper will be discoverable. Both clear that bar.

Where it does matter: if you're in a field with quantitative promotion criteria tied to journal IF thresholds, check what your institution uses. Some departments in Europe and Asia have hard floors (IF > 3.0 or IF > 4.0) that could make the difference here.

Where Scientific Reports Has the Edge

The Springer Nature brand isn't irrelevant. Scientific Reports benefits from publisher infrastructure that gives it higher library coverage, better metadata standards, and stronger SEO across academic search engines. Papers published in Scientific Reports tend to show up higher in Google Scholar searches for their topic area.

It's a marginal advantage, but in a volume-driven publishing environment, discoverability matters.

Scientific Reports also has a slightly stronger presence in physical sciences, earth and environmental sciences, and engineering compared to PLOS ONE. If your field isn't primarily biology or medicine, Scientific Reports is often where more of your peers publish.

Where PLOS ONE Has the Edge

PLOS ONE has a decade's head start and a cleaner institutional reputation. PLOS is an open-access nonprofit - that matters to some research communities, particularly in public health, global health, and fields with strong OA values. The PLOS brand communicates something that Springer Nature (a commercial publisher) doesn't.

PLOS ONE also has higher name recognition outside the academic world. Science journalists know PLOS ONE. Policy audiences know PLOS ONE. If any part of your work touches public audiences or media coverage, PLOS ONE has a slight edge in brand recognition.

For biological and biomedical sciences, PLOS ONE has historically been stronger - both in author community and citation density in the field. More biologists publish there, so more biologists read it.

Who Actually Does Well in Each Journal

Scientific Reports works well for:

• Physical scientists, earth scientists, and engineers who want megajournal coverage
• Researchers whose institution has a Springer Nature read-and-publish agreement (can reduce or eliminate APC)
• International researchers in fields where the Springer Nature name carries weight
• Work that needs to be published promptly and doesn't need novelty validation

PLOS ONE works well for:

• Biological and biomedical scientists, especially in public health or global health
• Researchers whose funders mandate PLOS-level OA compliance (common with Wellcome Trust, Bill & Melinda Gates Foundation)
• Work with clear public health implications that might get media attention
• Labs with institutional PLOS membership discounts

The One Thing Both Journals Can't Give You

Neither Scientific Reports nor PLOS ONE will help your paper get taken seriously by high-impact journals later. The megajournal model is a one-way door: once you publish there, you can't unsell the work to a better journal. If there's any realistic chance your paper belongs at Nature Communications, Science Advances, eLife, or a strong specialty journal, exhaust those options first.

The question to ask before submitting to either: "Am I choosing this journal because it's the right fit, or because I'm in a rush?" Both are legitimate reasons, but they're different. The second one can cost you career capital you didn't realize you had.

Summary and Recommendation

Scientific Reports and PLOS ONE are both defensible publication venues for technically sound research that doesn't meet the novelty bar of higher-impact journals. Scientific Reports has a marginally higher impact factor (3.9 vs 2.6) and stronger cross-disciplinary discoverability through Springer Nature's infrastructure. PLOS ONE has a stronger reputation in biological sciences, cleaner OA institutional positioning, and more name recognition outside academia.

For biology and biomedicine: lean toward PLOS ONE unless you have a Springer Nature institutional agreement that reduces the APC.

For physical sciences, earth science, and engineering: Scientific Reports is the more natural community.

For everything else: pick based on where your collaborators publish and where your target audience reads.

Frequently Asked Questions

Is Scientific Reports better than PLOS ONE?

Neither is definitively better. Scientific Reports has a slightly higher impact factor (3.9 vs 2.6) and stronger discoverability in physical sciences. PLOS ONE has a stronger reputation in biology and biomedicine and better brand recognition with non-academic audiences. The right choice depends on your field.

Do reviewers at Scientific Reports and PLOS ONE check for novelty?

No. Both journals use technical soundness as their primary publication criterion. Reviewers check whether your methods are sound and your conclusions follow from your data. They don't assess whether the findings are novel or significant enough. That's a deliberate design choice, not a quality problem.

Is Scientific Reports indexed in PubMed?

Yes. Scientific Reports is indexed in PubMed/MEDLINE. So is PLOS ONE. Both are indexed in Web of Science and Scopus. Indexing is not a differentiator between these two journals.

Are megajournal publications respected by hiring committees?

It depends on the field and institution. In biomedical sciences, a paper in Scientific Reports or PLOS ONE is respected as a legitimate publication but carries less weight than a paper in a high-impact specialty journal. For early-career researchers who need publications, both are completely appropriate venues. For senior academics, high-profile publications in top journals carry significantly more weight.

What's the fastest way to get published in Scientific Reports or PLOS ONE?

Both journals have comparable review timelines - roughly 3-5 months from submission to first decision. PLOS ONE has historically been slightly slower due to volume. Scientific Reports has reduced its backlog in recent years. Neither offers a genuinely fast-track option beyond standard submission.

The Bottom Line

Pick Scientific Reports if you're in physical sciences or have a Springer Nature deal that cuts the APC. Pick PLOS ONE if you're in biology or biomedicine, have funder mandates that align with PLOS's OA policies, or want more name recognition outside academia. Don't pick either as a first-choice target - exhaust journals with higher novelty thresholds before settling here.

Best for

• Authors deciding between these two venues for an active manuscript this month
• Labs that need a practical trade-off across fit, timeline, cost, and editorial bar
• Early-career researchers who need a realistic first-choice and backup choice

Not best for

• Choosing a journal from impact factor alone without checking scope fit
• Submitting before methods, controls, and framing match recent accepted papers
• Treating this comparison as a guarantee of acceptance at either journal

Sources

• Clarivate Journal Citation Reports 2024 - Impact Factor data for Scientific Reports and PLOS ONE
• PLOS ONE journal information page - plos.org/plosone
• Scientific Reports journal information - nature.com/srep
• PLOS ONE article processing charges - plos.org/publication-fees

See also

• Scientific Reports journal profile
• PLOS ONE journal profile
• Is PLOS ONE a good journal?
• Is Scientific Reports a good journal?
• eLife vs PLOS ONE: Which Should You Choose?
• How to choose a journal for your paper